Baxter Healthcare Corporation is recalling 402,165 vials of Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL) because the pH level of the solution may shift upward over time, exceeding the required safety specifications during its shelf life. This prescription medication is used to treat heart conditions and was manufactured for Claris Lifesciences and produced by Claris Injectables. If you have this medication, you should contact your healthcare provider or pharmacist immediately for guidance and return any unused product to the place of purchase for a refund.
A shift in the pH level of an injectable medication can change the stability and effectiveness of the drug, potentially causing localized irritation or reducing the intended therapeutic effect when administered to a patient.
Drug recall baseline remedy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.